ArticleFrontiers in veterinary science2026
Complete blood count-derived inflammatory markers in canine cerebrovascular accidents: diagnostic utility and prognostic implications.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cerebrovascular accident (CVA) is an under-recognized cause of acute neurological dysfunction in dogs. Although magnetic resonance imaging (MRI) supports diagnosis, the limited access and overlapping imaging features complicate its interpretation. Blood-based inflammatory indices such as the neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII) have shown diagnostic and prognostic value in human stroke; however, their clinical relevance in canine CVA has not been validated. Objectives: To evaluate the diagnostic and prognostic utility of the NLR and SII in dogs with MRI-confirmed CVA compared to healthy controls. Methods: Seventeen dogs with CVA and 20 healthy controls were analyzed retrospectively. The NLR and SII were calculated from complete blood counts at presentation. Functional outcomes were assessed using the Canine Functional Stroke Score (CFSS₀, CFSS₃₀). Associations with 30-day survival were analyzed between groups. Results: Dogs with CVA had significantly higher NLR and SII values than healthy controls. The receiver operating characteristic curves yielded areas under the curves of 0.82 (95% CI: 0.68-0.96) for NLR and 0.85 (95% CI: 0.71-0.99) for SII. The optimal cutoffs determined by the Youden index were 3.92 for NLR (sensitivity 70.6%, specificity 90.0%) and 1,352 for SII (sensitivity 76.5%, specificity 90.0%). Both markers were moderately correlated with poorer 30-day recovery. The SII was significantly higher in non-survivors than in survivors. Baseline CFSS was not significantly correlated with the degree of functional improvement but was significantly higher in non-survivors. Multivariate Cox proportional hazards regression model, neither the NLR nor the SII were significantly associated with survival. Although individual predictors did not reach statistical significance, the overall model demonstrated a significant association with 30-day survival. In the dichotomized analysis, the SII model demonstrated an improved model fit for predicting mortality, whereas the NLR model showed a poorer fit. Kaplan-Meier analysis showed that the high-SII group had lower survival rates than the low-SII group, while no significant difference in survival was observed between the NLR groups. Conclusion: NLR and SII may help differentiate dogs with CVA from healthy dogs and reflect clinical outcomes. The SII also shows potential prognostic value for short-term survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.